Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721
Price:
9.26
CNY
-0.11%
Market Cap:
¥3.6B
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Other
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
Inner Mongolia BaoTou Steel Union Co Ltd
SSE:600010
|
Other
-¥2.7B
|
CAGR 3-Years
-46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Baoshan Iron & Steel Co Ltd
SSE:600019
|
Other
-¥2.5B
|
CAGR 3-Years
-61%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-17%
|
|
|
W
|
Western Superconducting Technologies Co Ltd
SSE:688122
|
Other
¥6.6m
|
CAGR 3-Years
-86%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
|
C
|
CITIC Pacific Special Steel Group Co Ltd
SZSE:000708
|
Other
¥1.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Inner Mongolia Dazhong Mining Co Ltd
SZSE:001203
|
Other
¥53.3m
|
CAGR 3-Years
-69%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Glance View
Xinjiang Baihuacun Pharam Tech Co., Ltd. provides medical research and development services as a contract research organization (CRO). The company is headquartered in Urumqi, Xinjiang and currently employs 722 full-time employees. The firm's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The firm is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The firm is also engaged in leasing and property services. The firm mainly conducts business within the domestic market.
Intrinsic Value
3.34
CNY
Overvaluation 64%
